Annual D&A
$604.50 K
+$8500.00+1.43%
June 30, 2024
Summary
- As of February 7, 2025, INM annual depreciation & amortization is $604.50 thousand, with the most recent change of +$8500.00 (+1.43%) on June 30, 2024.
- During the last 3 years, INM annual D&A has risen by +$375.80 thousand (+164.32%).
- INM annual D&A is now -72.72% below its all-time high of $2.22 million, reached on July 31, 2001.
Performance
INM Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$145.00 K
-$6900.00-4.54%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly depreciation & amortization is $145.00 thousand, with the most recent change of -$6900.00 (-4.54%) on September 30, 2024.
- Over the past year, INM quarterly D&A has dropped by -$5700.00 (-3.78%).
- INM quarterly D&A is now -69.60% below its all-time high of $476.90 thousand, reached on October 31, 2001.
Performance
INM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$600.20 K
-$4400.00-0.73%
September 30, 2024
Summary
- As of February 7, 2025, INM TTM depreciation & amortization is $600.20 thousand, with the most recent change of -$4400.00 (-0.73%) on September 30, 2024.
- Over the past year, INM TTM D&A has dropped by -$3500.00 (-0.58%).
- INM TTM D&A is now -67.49% below its all-time high of $1.85 million, reached on July 31, 2002.
Performance
INM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
INM Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.4% | -3.8% | -0.6% |
| 3 y3 years | +164.3% | -5.9% | +17.3% |
| 5 y5 years | +538.3% | +48.1% | +233.6% |
INM Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.3% | -5.9% | at low | -0.9% | +95.3% |
| 5 y | 5-year | at high | +538.3% | -5.9% | +439.0% | -0.9% | +460.9% |
| alltime | all time | -72.7% | -100.0% | -69.6% | +308.0% | -67.5% | -100.0% |
InMed Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $145.00 K(-4.5%) | $600.20 K(-0.7%) |
| Jun 2024 | $604.50 K(+1.4%) | $151.90 K(+0.8%) | $604.60 K(+0.1%) |
| Mar 2024 | - | $150.70 K(-1.2%) | $603.70 K(+0.2%) |
| Dec 2023 | - | $152.60 K(+2.1%) | $602.20 K(+0.9%) |
| Sep 2023 | - | $149.40 K(-1.1%) | $597.00 K(+0.2%) |
| Jun 2023 | $596.00 K(+16.5%) | $151.00 K(+1.2%) | $596.10 K(-0.5%) |
| Mar 2023 | - | $149.20 K(+1.2%) | $599.20 K(-0.7%) |
| Dec 2022 | - | $147.40 K(-0.7%) | $603.30 K(-0.4%) |
| Sep 2022 | - | $148.50 K(-3.6%) | $605.90 K(+18.4%) |
| Jun 2022 | $511.80 K(+123.8%) | $154.10 K(+0.5%) | $511.80 K(+26.2%) |
| Mar 2022 | - | $153.30 K(+2.2%) | $405.60 K(+32.0%) |
| Dec 2021 | - | $150.00 K(+175.7%) | $307.30 K(+20.4%) |
| Sep 2021 | - | $54.40 K(+13.6%) | $255.20 K(+11.5%) |
| Jun 2021 | $228.70 K(+103.5%) | $47.90 K(-12.9%) | $228.80 K(+10.1%) |
| Mar 2021 | - | $55.00 K(-43.8%) | $207.80 K(+15.5%) |
| Dec 2020 | - | $97.90 K(+249.6%) | $179.90 K(+63.2%) |
| Sep 2020 | - | $28.00 K(+4.1%) | $110.20 K(-2.0%) |
| Jun 2020 | $112.40 K(+18.7%) | $26.90 K(-0.7%) | $112.40 K(+2.6%) |
| Mar 2020 | - | $27.10 K(-3.9%) | $109.60 K(+2.4%) |
| Dec 2019 | - | $28.20 K(-6.6%) | $107.00 K(+6.2%) |
| Sep 2019 | - | $30.20 K(+25.3%) | $100.80 K(+6.6%) |
| Jun 2019 | $94.70 K(+5.7%) | $24.10 K(-1.6%) | $94.60 K(+2.2%) |
| Mar 2019 | - | $24.50 K(+11.4%) | $92.60 K(+2.7%) |
| Dec 2018 | - | $22.00 K(-8.3%) | $90.20 K(-2.1%) |
| Sep 2018 | - | $24.00 K(+8.6%) | $92.10 K(+2.8%) |
| Jun 2018 | $89.60 K(+19.1%) | $22.10 K(0.0%) | $89.60 K(+2.9%) |
| Mar 2018 | - | $22.10 K(-7.5%) | $87.10 K(0.0%) |
| Dec 2017 | - | $23.90 K(+11.2%) | $87.10 K(+9.4%) |
| Sep 2017 | - | $21.50 K(+9.7%) | $79.60 K(+5.9%) |
| Jun 2017 | $75.20 K(+11.6%) | $19.60 K(-11.3%) | $75.20 K(+3.2%) |
| Mar 2017 | - | $22.10 K(+34.8%) | $72.90 K(+4.6%) |
| Dec 2016 | - | $16.40 K(-4.1%) | $69.70 K(+1.9%) |
| Sep 2016 | - | $17.10 K(-1.2%) | $68.40 K(+1.5%) |
| Jun 2016 | $67.40 K(-11.1%) | $17.30 K(-8.5%) | $67.40 K(-1.6%) |
| Mar 2016 | - | $18.90 K(+25.2%) | $68.50 K(+9.6%) |
| Dec 2015 | - | $15.10 K(-6.2%) | $62.50 K(-3.5%) |
| Sep 2015 | - | $16.10 K(-12.5%) | $64.80 K(-14.5%) |
| Jun 2015 | $75.80 K(>+9900.0%) | $18.40 K(+42.6%) | $75.80 K(+32.1%) |
| Mar 2015 | - | $12.90 K(-25.9%) | $57.40 K(+29.0%) |
| Dec 2014 | - | $17.40 K(-35.8%) | $44.50 K(+64.2%) |
| Sep 2014 | - | $27.10 K(>+9900.0%) | $27.10 K(>+9900.0%) |
| Jun 2014 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2013 | $0.00(-100.0%) | - | - |
| Jun 2011 | $135.50 K(+95.0%) | $68.00 K(+185.7%) | $135.50 K(+5.4%) |
| Mar 2011 | - | $23.80 K(+5.8%) | $128.60 K(+19.6%) |
| Dec 2010 | - | $22.50 K(+6.1%) | $107.50 K(+22.7%) |
| Sep 2010 | - | $21.20 K(-65.3%) | $87.60 K(+26.0%) |
| Jun 2010 | $69.50 K(-58.8%) | $61.10 K(+2163.0%) | $69.50 K(+179.1%) |
| Mar 2010 | - | $2700.00(+3.8%) | $24.90 K(+27.7%) |
| Dec 2009 | - | $2600.00(-16.1%) | $19.50 K(+596.4%) |
| Sep 2009 | - | $3100.00(-81.2%) | $2800.00(-98.3%) |
| Jun 2009 | $168.80 K(+102.9%) | $16.50 K(-711.1%) | $168.80 K(-6.3%) |
| Mar 2009 | - | -$2700.00(-80.9%) | $180.10 K(-16.6%) |
| Dec 2008 | - | -$14.10 K(-108.3%) | $215.90 K(-6.6%) |
| Sep 2008 | - | $169.10 K(+508.3%) | $231.20 K(+177.6%) |
| Jun 2008 | $83.20 K(-50.9%) | $27.80 K(-16.0%) | $83.30 K(-48.2%) |
| Mar 2008 | - | $33.10 K(+2658.3%) | $160.90 K(+176.9%) |
| Dec 2007 | - | $1200.00(-94.3%) | $58.10 K(-35.4%) |
| Sep 2007 | - | $21.20 K(-79.9%) | $89.90 K(-47.0%) |
| Jun 2007 | $169.60 K(-32.8%) | $105.40 K(-251.2%) | $169.70 K(+9.6%) |
| Mar 2007 | - | -$69.70 K(-311.2%) | $154.80 K(-42.9%) |
| Dec 2006 | - | $33.00 K(-67.3%) | $271.20 K(-7.5%) |
| Sep 2006 | - | $101.00 K(+11.6%) | $293.30 K(+16.2%) |
| Jun 2006 | $252.50 K(-40.8%) | $90.50 K(+93.8%) | $252.50 K(+56.1%) |
| Mar 2006 | - | $46.70 K(-15.2%) | $161.80 K(-42.9%) |
| Dec 2005 | - | $55.10 K(-8.5%) | $283.50 K(-29.6%) |
| Sep 2005 | - | $60.20 K(<-9900.0%) | $402.70 K(-5.6%) |
| Jun 2005 | $426.30 K(+44.1%) | -$200.00(-100.1%) | $426.40 K(-13.8%) |
| Mar 2005 | - | $168.40 K(-3.4%) | $494.40 K(+25.3%) |
| Dec 2004 | - | $174.30 K(+107.7%) | $394.60 K(+32.5%) |
| Sep 2004 | - | $83.90 K(+23.7%) | $297.80 K(+0.7%) |
| Jul 2004 | $295.90 K(-22.3%) | $67.80 K(-1.2%) | $295.80 K(+4.4%) |
| Apr 2004 | - | $68.60 K(-11.5%) | $283.20 K(-2.7%) |
| Jan 2004 | - | $77.50 K(-5.4%) | $291.10 K(-8.1%) |
| Oct 2003 | - | $81.90 K(+48.4%) | $316.70 K(-16.8%) |
| Jul 2003 | $380.70 K(-79.4%) | $55.20 K(-27.8%) | $380.70 K(-49.6%) |
| Apr 2003 | - | $76.50 K(-25.8%) | $755.80 K(-34.4%) |
| Jan 2003 | - | $103.10 K(-29.3%) | $1.15 M(-24.0%) |
| Oct 2002 | - | $145.90 K(-66.1%) | $1.52 M(-17.9%) |
| Jul 2002 | $1.85 M(-16.7%) | $430.30 K(-8.9%) | $1.85 M(+30.4%) |
| Apr 2002 | - | $472.20 K(+1.1%) | $1.42 M(+50.0%) |
| Jan 2002 | - | $467.00 K(-2.1%) | $943.90 K(+97.9%) |
| Oct 2001 | - | $476.90 K | $476.90 K |
| Jul 2001 | $2.22 M | - | - |
FAQ
- What is InMed Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual D&A year-on-year change?
- What is InMed Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly D&A year-on-year change?
- What is InMed Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals TTM D&A year-on-year change?
What is InMed Pharmaceuticals annual depreciation & amortization?
The current annual D&A of INM is $604.50 K
What is the all time high annual D&A for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual depreciation & amortization is $2.22 M
What is InMed Pharmaceuticals annual D&A year-on-year change?
Over the past year, INM annual depreciation & amortization has changed by +$8500.00 (+1.43%)
What is InMed Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of INM is $145.00 K
What is the all time high quarterly D&A for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly depreciation & amortization is $476.90 K
What is InMed Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, INM quarterly depreciation & amortization has changed by -$5700.00 (-3.78%)
What is InMed Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of INM is $600.20 K
What is the all time high TTM D&A for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high TTM depreciation & amortization is $1.85 M
What is InMed Pharmaceuticals TTM D&A year-on-year change?
Over the past year, INM TTM depreciation & amortization has changed by -$3500.00 (-0.58%)